A review on schizophrenia and relapse - A quest for user-friendly psychopharmacotherapy

Takefumi Suzuki, Hiroyuki Uchida, Hiroyoshi Takeuchi, Takashi Tsuboi, Jinichi Hirano, Masaru Mimura

研究成果: Review article査読

27 被引用数 (Scopus)


Objective: Schizophrenia in general is notoriously associated with relapses rendering the illness progressive to worse outcomes, a concept of which is compatible with neurotoxicity. Therefore, relapse prevention is of utmost clinical relevance. Methods: In this review, we aim to put relapse into clinical context in the realm of natural history of, or heterogeneity in, schizophrenia and summarize risk factors of relapse. We discuss how to effectively ' define' relapse in schizophrenia and recent meta-analytic studies on this topic to highlight the importance of continuous antipsychotic treatment. Results: The following issues emerged: 'How low maintenance antipsychotic dosage could be?', 'How extended dosing could be?', 'Who could be successfully withdrawn from antipsychotics?' and 'How relapse could be defined in the first place?' The question in particular is how better to deliver antipsychotics at the lowest possible, whereby dose and dosing interval are relevant. While ongoing antipsychotic treatment is the rule, recent works are pointing to a possibility of lower dosage in the maintenance phase of the illness. Conclusions: Bearing in mind that suboptimal adherence and withdrawal from antipsychotics are an established and unequivocal risk factor for relapse, further investigations are certainly needed to explore user-friendly manner of psychopharmacotherapy to prevent relapse in schizophrenia.

ジャーナルHuman Psychopharmacology
出版ステータスPublished - 2014 9月 1

ASJC Scopus subject areas

  • 神経学
  • 臨床神経学
  • 精神医学および精神衛生
  • 薬理学(医学)


「A review on schizophrenia and relapse - A quest for user-friendly psychopharmacotherapy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。